Trial Profile
Duloxetine versus venlafaxine extended release in the treatment of major depressive disorder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary) ; Venlafaxine
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 15 Jun 2006 New trial record.